Teva's Stock Slides After U.S. Sues Over Copay Kickback Claims | Barron's
Teva Stock Has Crumbled, and Chairman Sol Barer Is Buying Up Shares | Barron's
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Generic-drug stocks slammed by report of expanded price-fixing probe - MarketWatch
Well, well,we'll...said he didn't know why “his team” invested which lowered the stock for months then just doubled his… | Dow jones companies, Investing, Dow jones
Teva: Avoid (NYSE:TEVA) | Seeking Alpha
Teva shares surge on corporate shake-up - MarketWatch
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
Is Teva A Falling Drug Company Or A Great Value Proposition (NYSE:TEVA) | Seeking Alpha
Teva Stock Pressured From Antitrust Lawsuit Against Drug Makers | Barron's
I-Mab's IL-6 Drug Hits Primary Endpoint Goal In Mid-Stage Ulcerative Colitis Study
Teva releases generic version of Mylan's EpiPen in limited doses in the U.S. - MarketWatch
Teva Appoints New Chief Executive After Months of Speculation - WSJ
Teva's generic EpiPen approved in the U.S., with perfect timing - MarketWatch
Teva stock drops 10% as generics turnaround looks uncertain - MarketWatch
Teva to acquire Mexico's Rimsa for $2.3 billion - MarketWatch
Teva Pharmaceuticals (@TevaUSA) / Twitter
Drug maker Teva's U.S. unit indicted on price-fixing charges - MarketWatch
Mylan sees opportunity in rival Teva's weakness - MarketWatch
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
Teva Stock Sees Another Big Buy From Chairman Sol Barer | Barron's
Teva Pharmaceutical Is in Recovery - WSJ
Teva shares rise as company offers reassurance on former flagship drug Copaxone - MarketWatch
